Every patent Is important. They should PR everyone of them. Cost to Pr isn’t that much. Also this one isn’t assigned to covidien unlike some of the other IP.
More important is that Mcnally keeps to his word about being more transparent to shareholders. So far it’s the same playbook.
News 
Market Data 
Discover 
AI
